Scholars Central

Conference abstractPublished 2016

Particle analysis methodologies to study protein aggregates

Authors: Yuanchun Zeng

MilliporeSigma, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The presence of proteinaceous (aggregates) and non-proteinaceous particulates in biological drug manufacturing is of great concern due to potential effects on product safety, efficacy, and immunogenicity. Therefore, FDA requires that aggregates and particles be closely monitored. SEC-HPLC is the most commonly used method for aggregate detection and quantification; still there are limitations to SEC for analysis: SEC cannot detect insoluble aggregates as well as sub-visible and visible particles, the conditions required to perform SEC often dissociate reversible aggregates. Therefore, complementary analytical methods (such as DLS, fluidic imaging, fluorescent imaging) are essential to ensure that a broad range of aggregates/particles are detected. This poster will present multiple aggregates analysis tools that will present the complete profile of protein aggregates.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Pharmaceutics & Drug Delivery Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Pharmaceutics & Drug Delivery Research
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Yuanchun Zeng”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels